AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Eli Lilly & Co. is tapping the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of ...

Although common, the cause of these hernias is unknown, and the only treatment ... Cancer Vaccine Shows Promise for Patients With Stage III and IV Kidney Cancer Feb. 5, 2025 — Researchers report ...

Scientists have successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence to transform the drug discovery pipeline.

As space travel gains traction and astronauts spend increasing amounts of time in space, studying its effects on health has ...

“Patients sometimes tell me that they ‘hear bad things’ about [ED treatments],” Dr. Gross told The Post. “These medications are among the most broadly prescribed drugs of the last ...